This article corrects:

  1. Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C Volume 149, Issue 2, 244–249, Article first published online: 5 February 2010

In Fenaux et al (2010), the scale of the Y-axis for Haemoglobin panel (A) in Figure 3 should be −10 to +20 and not −100 to 200 as published. The correct figure appears below.

  • image(3)

[  Mean (±SE) changes from baseline for haemoglobin (A), platelets (B) and absolute neutrophil count (C). *‘Last observation carried forward’ methodology used for both azacitidine and LDara-C groups. ]